Valneva
Valneva SE, a French specialty vaccine company, commercializes IXIARO (Japanese encephalitis) and DUKORAL (cholera & ETEC) and develops pipeline candidates VLA15 (Lyme), VLA1553 (chikungunya), VLA2001 (COVID‑19). Global reach with collaborations at Pfizer and Instituto Butantan.
Headquarters: France (FRA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Family Planning Centers
- Employees: 713
- HQ: Saint-Herblain
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.